Cancel anytime
CalAmp Corp (CAMP)CAMP
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/12/2024: CAMP (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -66.02% | Upturn Advisory Performance 1 | Avg. Invested days: 24 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 06/12/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -66.02% | Avg. Invested days: 24 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 06/12/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - |
Volume (30-day avg) 368396 | Beta - |
52 Weeks Range 5.15 - 12.30 | Updated Date 11/12/2024 |
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - | Volume (30-day avg) 368396 | Beta - |
52 Weeks Range 5.15 - 12.30 | Updated Date 11/12/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE - |
Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding - | Shares Floating - |
Percent Insiders - | Percent Institutions - |
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating 4.5 | Target Price - | Buy 2 |
Strong Buy 2 | Hold - | Sell - |
Strong Sell - |
Rating 4.5 | Target Price - | Buy 2 | Strong Buy 2 |
Hold - | Sell - | Strong Sell - |
AI Summarization
CalAmp Corp.: A Comprehensive Overview
Company Profile:
History and Background:
CalAmp Corp. (NASDAQ: CAMP), established in 1992, is a leading provider of wireless communications solutions. Their journey began with innovative satellite paging systems and has evolved to encompass a wider spectrum of technologies, including cellular, satellite, and LoRaWAN®. Today, they offer a comprehensive suite of SaaS solutions, telematics devices, and software for the connected car, industrial, and asset tracking markets.
Core Business Areas:
- Wireless Connectivity: CalAmp offers a wide range of wireless modules and gateways that enable reliable communication in diverse environments.
- Telematics: They provide cloud-based platforms and hardware for tracking and managing mobile assets, generating insights for optimizing operations.
- SaaS Applications: CalAmp develops software solutions for various applications, including fleet management, field service, and connected car services.
Leadership and Corporate Structure:
CalAmp is led by President and CEO Jeff Gardner, a seasoned technology executive with extensive experience in driving growth and innovation. The company operates under a board of directors and maintains a corporate structure focused on operational efficiency and agility.
Top Products and Market Share:
- Telematics Devices: CalAmp's flagship products include telematics devices like the iOn, LM20, and MT90, offering real-time asset tracking and data analysis capabilities.
- Cloud-based Platforms: Their SaaS platforms, including LocaTrack, TractGear, and iOnVision, provide advanced data visualization, reporting, and analytics tools.
Market Share:
CalAmp holds a significant market share in the connected car and asset tracking segments. In the North American fleet management market, they claim a 25% share, while in the global LoRaWAN market, they hold a 15% share. Their market position is further bolstered by strategic partnerships with leading technology providers.
Comparison to Competitors:
CalAmp's main competitors include Geotab (GEOT), Verizon Connect (VZ), and Trimble (TRMB). While competitors offer similar products, CalAmp differentiates itself through its comprehensive portfolio, robust technology platform, and focus on vertical market expertise.
Total Addressable Market:
The global market for telematics and asset tracking is estimated to reach $25.4 billion by 2027. The connected car segment alone is projected to grow at a CAGR of 17.5%, reaching $195.4 billion by 2028. This vast and rapidly expanding market presents significant opportunities for CalAmp's future growth.
Financial Performance:
Revenue and Profitability: In their most recent fiscal year, CalAmp reported revenue of $292.3 million, with a net income of $23.1 million. This translates to a profit margin of 7.9% and earnings per share (EPS) of $0.85.
Year-over-Year Comparison: Revenue has grown by 5% year-over-year, indicating steady progress. However, profitability remains under pressure due to increased operating expenses.
Cash Flow and Balance Sheet: CalAmp maintains a strong cash position with $74.2 million in cash and equivalents. Their balance sheet reflects healthy liquidity, with current assets exceeding current liabilities.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CAMP4 THERAPEUTICS CORPORATION
Exchange | NASDAQ | Headquaters | Cambridge, MA, United States |
IPO Launch date | 2024-10-11 | CEO, President & Director | Mr. Joshua Mandel-Brehm |
Sector | Healthcare | Website | https://www.camp4tx.com |
Industry | Biotechnology | Full time employees | 58 |
Headquaters | Cambridge, MA, United States | ||
CEO, President & Director | Mr. Joshua Mandel-Brehm | ||
Website | https://www.camp4tx.com | ||
Website | https://www.camp4tx.com | ||
Full time employees | 58 |
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001 for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP to treat synaptic Ras GTPase activating protein 1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.